References

Home Page

https://www.mundipharma.ie/

  1. https://www.irishtimes.com/life-and-style/health-family/type-2-diabetes-alarming-rise-in-number-at-risk-1.3481431
  2. https://www.hse.ie/eng/health/hl/living/asthma/aboutasthma/

Diabetes Page

https://www.mundipharma.ie/patient-information/diabetes

  1. https://www.who.int/news-room/fact-sheets/detail/diabetes
  2. https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/symptoms-causes/syc-20351193
  3. https://www.diabetes.ie/about-us/diabetes-in-ireland/)
  4. https://www.diabetes.ie/wp-content/uploads/2014/11/Living-Well-eith-Type-2-with-updated-Pyramid-June-2017.pdf
  5. https://www.diabetes.org.uk/preventing-type-2-diabetes/diabetes-risk-factors
  6. https://www.diabetes.ie/living-with-diabetes/living-with-type-2/

 

Respiratory Page

https://www.mundipharma.ie/patient-information/respiratory

  1. Msoli, M,Fabian, D, Holt, S, et al Global Initiative for Asthma (GINA) program: the global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59,469-478.

Biosimilars Page

https://www.mundipharma.ie/patient-information/biosimilars

  1. European Medicines Agency https://www.ema.europa.eu/en/documents/leaflet/biosimilars-eu-information-guide-healthcare-professionals_en.pdf
  2. https://health.gov.ie/wp-content/uploads/2017/08/National-Biosimilar-Medicines-Policy-Consultation-Paper-2017.pdf
  3. https://www.medicinesforeurope.com/wp-content/uploads/2016/03/IMS-Institute-Biosimilar-Report-March-2016-FINAL.pdf
  4. https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/symptoms-causes/syc-20351193 Page 6
  5. https://health.gov.ie/blog/policy/b/biosimilars/
  6. http://www.hpra.ie/homepage/medicines/special-topics/biosimilar-medicines/questions-and-answers-for-patients